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ABSTRACT 
Traditional methods for laboratory diagnosis of tuberculosis (TB) may require weeks, and delays can 
impede treatment and control efforts. Nucleic acid amplification (NAA) tests, such as polymerase chain 
reaction (PCR) and other methods for amplifying DNA and RNA, may facilitate rapid detection of 
microorganisms. This study emphasized our three years experience in the diagnosis of TB on clinical 
samples using the PCR method. Among 531 patients with suspected TB, 112 (21.3%) were positive by 
PCR, while 419 (78.7 %) were negative. The specimens collected from TB suspected patients were sputum, 
blood, ascitic fluid, pleural fluid, and gastric wash. Blood samples showed high positive results 15/41 (34%) 
in comparison with sputum samples which is the most frequent sample 64/ 285 (22.3%). Gastric wash 
samples reported low rate of  
positive result 1/30 (3.3%). This rapid and sensitive test compared with the other cultural and microscopic 
tests have now been incorporated into our laboratory practice allowing the physicians to manage proper 
diagnosis and drug regimens. 
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INTRODUCTION 
The human pathogenic bacterium Mycobacterium Tuberculosis (TB), is the causative agent of tuberculosis, 
infects an estimated one-third of the world’s population, resulting in 8 million tuberculosis cases and 2 
million deaths each year (Pai, Kalantri et al. 2006). Tuberculosis (TB) continues to be a major public health 
challenge worldwide. HIV-TB coinfection is especially important and worrying as it accelerates 
progression of infection to active disease and amplifies spread of TB including drug resistant organism or 
bacilli  (Glassroth 2005). The currently accepted ‘‘gold standard’’ laboratory method for detecting and 
identifying Mycobacterium tuberculosis is a combination of ZN-stained acid-fast bacillus (AFB) smear for 
initial screening and culture for bacterial isolation and identification (Hall et al 1994). Smears lack both 
sensitivity and specificity for Mycobacterium tuberculosis, and cultures usually require weeks before the 
species is definitively identified (Daniel, 1990; Kent and Kubica, 1985). The acid-fast smear test also is 
unable to distinguish among mycobacterial species. Ongut, et al (2006) evaluated the validity of an 
immunochromatographic assay, ICT Tuberculosis test for the serologic diagnosis of TB in Antalya, Turkey. 
They found that smear-positive pulmonary TB patients showed a higher positivity rate for antibodies than 
smear-negative patients, but the difference was not statistically significant. They suggest that ICT 
Tuberculosis test can be used to aid TB 
diagnosis in smear-positive patients until the culture results are available (Ongut, Ogunc et al. 2006) 
Therefore, the top priority for TB diagnostic development worldwide is a low-cost, rapid, sensitive, and 
specific test that could replace the acid-fast smear examination (Cho and Brennan 2007). In addition, only 
half of all cases of active TB worldwide are smear-positive. Most smear-negative TB cases are ignored and 
remain undiagnosed. Therefore, improved diagnostic methods for smear-negative TB are also needed. 
Microscopy and culture are still the major backbone for laboratory diagnosis of tuberculosis (TB); new 
methods including molecular diagnostic tests have evolved over the last two decades (Cho and Brennan 
2007). PCR amplification can be rapidly performed by using primers for a highly conserved sequence 
within a gene common to all mycobacterial species to amplify minute amounts of DNA (Watson et al 1992); 
specificity for M. tuberculosis is achieved during the detection step. PCR allows the amplification of a 
targeted DNA sequence over 106-fold through cycles of primer annealing and nucleotide extension of target 
sequences by DNA polymerase at specific temperatures (Persing, 1993, Piper, and Unger1998). Research 
developments with PCR for the direct detection of M. tuberculosis in clinical specimens have demonstrated 
the possible use of PCR in providing a rapid diagnosis of tuberculosis (Stahl, and Urbance. 1990; Sibata 
and Togashi, 1992; Narita, et al., 1992; Victor et al., 1992). The Department of Molecular Biology, Institute 
of Nuclear Medicine Molecular Biology and Oncology (INMO) introduced PCR molecular technique to 
perform a molecular diagnostic service for patients and their physicians in the infectious diseases such as 
TB, HBV, HIV, and Chlamydia. The aims of this paper is to evaluate the molecular diagnostic services in 
the department and to emphasize our three years experience in the molecular diagnosis of tuberculosis and 
identify the best sample for miliary TB diagnosis. 
 
MATERIALS AND METHOD 
Between 2004 and 2007, 513 TB suspects (304 males and 227 females) were enrolled in the Molecular 
Diagnosis Unit at the Department of Molecular Biology at (INMO). The mean age of the patients was 36.65 
± 23.17 (min 1year - max 96 years old). This service serves different parts of Gezira state in addition to 
other surrounding states such as Khartoum, Sinnar and Gadarif states. The molecular test focused on 
detection of nucleic acids DNA specific to Mycobacterium tuberculosis, using polymerase chain reaction 
(PCR); amplification techniques. 
DNA Extraction  
DNA was extracted using DNPTM kit (cinnaGen Inc, Cat. No.DN115C form Iran) which was designed to 
isolate double stranded DNA form human and animal sources. Sputum samples were treated by Sodium 
˚C for 3 hrs, 
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and then transferred to water bath at 950C for 20 min. , The CSF, ascitic fluid, pleural fluid were centrifuged 
and the supernatants were discarded, the rest were used for DNA extraction. 
The lysis solution was pre warmed by placing in 37˚C fo
-20 sec. After 
for 
3-5 sec and placed in -20˚C for 20 min then centrifuged at 12,000g for 10 min. The supernatant was decanted 
gently and placed the tube in tissue paper for 2-3 
sec. 1ml of wash buffer was added to the pellet and mixed by 3-5 sec vortexing and centrifuge at 12000 g 
for 5 min. The wash buffer was poured completely and the pellet was dried at 65˚C for 5 min. The pellet 
precipitated by centrifugation for 30 sec at 12000g. The supernatant contain purified DNA.      
Polymerase chain reaction (PCR)    
Mycobacterium tuberculosis PCR detection kit (CinnaGen Inc Iran (cat.No. PR7935C)) was used for 
diagnosis in addition to negative and positive controls were provided by the company. The total volume of 
-DNA polymerase. The 
mixture was spun for 3-5 sec, then the tubes were transferred to preheated thermocycler machine, the 
program started as followed, initial denaturation at  94˚C for 10 min, the following temperature profile: 
94˚C for 1 min for denaturation., 72˚C for 2 min for annealing,  72˚C for 3 min for extension followed by 
30 cycles and end with 4˚ re loaded directly in  2% agrose gel 
for documentation.   
 
RESULTS 
The presence of 163 bp fragments of PCR product comparing with DNA size ladder indicates positive result 
as in shown figure (1). There were about sixteen different types of samples as shown in figure (2). 
The molecular diagnostic test shows that 112 (21.3%) had a positive result by PCR while 419 (78.7 %) had 
a negative PCR results as shown in figure (3).  The mean age of positive samples was 36.21 ± 21.07 (min2- 
max 95 years old), the sex distribution of the positive samples is shown on figure (4). Most of the  
samples, (n=87) came from patients more than 60 years old (16.4%), then (n=54) from 36-40 years old  
(10.2%) as in figure (5). The comparison between the total samples and the positive ones showed higher 
positive samples are from (n=16) patients between 21-25 years old (14.3 %), of whom ten (62.5%) were 
females while only six were males (37.5%). The Types of TB in this age group were nine pulmonary 
tuberculosis, six were abdominal tuberculosis and one bone TB. The types of samples were sputum, ascitic 
pleural fluid as well as blood. 
The analysis of the positive PCR result according to the type of samples showed that blood samples had a 
high positive result (34.1% ) compared with the other samples, while the gastric wash showed very low 
positive results (3.3%) , pleural fluid sputum and  ascitic fluid were in the same range 23.1%, 22.3% and 
18.1 % respectively as shown in table 1.  
All sputum samples are diagnosed clinically as pulmonary TB. The clinical diagnosis for ascitic fluid, ten 
were abdominal TB and two were unspecified while only one pulmonary tuberculosis. As PCR the clinical 
diagnosis for the blood samples, six were diagnosed as bone tuberculosis, while one case diagnosed for 
each cancer larynx, pulmonary tuberculosi, pericardial TB, lip TB and cryptogenic tuberculosis. Three did 
not have a clear clinical diagnosis. The clinical diagnoses of the positive pleural fluid were seven as 






Gezira Journal Of Health Sciences 2008 vol.2(1)  
 
Gezira Journal Of Health Sciences 2006 vol.2(1) 
 




Figure (2): shows the different types of sample for TB diagnosis (N=531) 
 
Figure (3) shows the total PCR result of the samples(N=531) 
 
 
Figure (4) shows Distribution of sex among positive cases (N=112) 
Lane 1 ladder, lane 2 negative control, lane 3 positive 
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Figure (5) :The Distribution of age group in the all (N=531) and positive cases (N=112) 
 
Table (1): The Distribution of PCR positive result in Different types of samples 
Type of sample Positive (%) Negative (%) Total samples (%) 
Sputum 64 (22.3) 221(77.7) 285 (53.7) 
Acetic fluid 15 (18.1) 69 (81.9)  84 (15.8) 
Pleural fluid 12 (23.1) 41 (76.9) 53 (10.0) 
Blood 15 (34.1) 26 (65.9) 41 (07.7) 
Gastric wash 1 (03.3) 29 ( 96.7) 30  (05.6) 
Others 5 (13.2) 33 (86.8)  38 (07.2) 
Total 112 (21.3) 419 (78.7) 531(100) 
 
DISCUSSION 
Current global TB control efforts are based on diagnosis of cases followed by adequate treatment. It is 
important that diagnosis be established early and efficiently in order to prevent misdiagnosis and continued 
transmission. In environments with high prevalence of TB, better tests and more-efficient diagnostic 
processes are needed. 
Microscopy and culture are still the major backbone for laboratory diagnosis of tuberculosis (TB), but the 
molecular methods for identifying organisms, strain typing, and determining drug susceptibilities are 
extremely valuable for pathogens that are impossible to grow on artificial media, slow growing on artificial 
media, or exceptionally hazardous to grow in a clinical microbiology laboratory (Marks 1993). 
Conventional methods for the identification of mycobacteria are slow and labour intensive. DNA 
amplification methods offer rapid sensitive and specific diagnosis (Magana-Arachch et al, 2008) test for 
samples that are difficult to be diagnosed by conventional methods. Our data showed that, the majority of 
the samples were sputums; however, the blood samples a high positive result. This finding can facilitate 
the clinical diagnosis of millary TB and bone TB which were found difficult to be diagnosed in other 
specimens like sputum. In contrast, the samples of gastric wash reported low positive sample. This may be 
due to the sample handling, collection or dilution.  
The routine molecular tests have now been incorporated into laboratory practice allowing the physicians 
to more rapidly initiate proper drug regimens. In addition, particular emphasis should be applied to quality 
control and quality assurance programs in the labouratories. Although nucleic acids amplification tests 
(NAA) have been offered by individual labouratories, approval of commercial kits may result in increased 
use of NAA in clinical practices in general and for TB control in particular. In our Department, more than 
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increase of the understanding of the role of the molecular diagnosis techniques. Our results open the way 
to a simplified diagnostic screening procedure in which the conventional methods can be replaced.  
However, cost-effectiveness studies and operational studies are required to support an evidence based 
decision to introduce PCR for TB control in high-burden environments. Also further investigations are 
needed to assess the PCR kits , different types of samples and negative PCR results the responded to clinical 
and therapeutic trails   
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